RARE: Ultragenyx Pharma Expected earnings per share growth for next year

Public company logo of Ultragenyx Corp (RARE)

Ultragenyx Pharmaceutical is a recognized leader in the therapy of ultra-rare genetic pathologies that has earned the deep trust of patients. The GURU.Markets service provides an assessment of the expected EPS growth for the coming year, where the 105.20 mark serves as a key metric. Stable demand for unique drugs guarantees crisis resilience, while organic development through the licensing of scientific discoveries ensures long-term R&D growth.

RARE - Ultragenyx Corp Projected earnings per share growth rate for next year over the range 07/04/2022 - 11/18/2026

Ultragenyx (RARE) - metric breakdowns and financial figures

- price and consensus price forecast:
Fundamental company valuation:Ultragenyx Corp, RARE
Core merchandise of ultragenyx.com

This indicator reflects the aggregated consensus growth forecast for net income, allowing for an assessment of the gap between management's declarations and actual market demand. By analyzing changes in the consensus earnings per share (EPS) forecast, investors can identify the monetization potential of Ultragenyx Pharmaceutical (RARE) orphan drug status, where monopoly pricing power converts directly into financial stability and future business yield growth.

Main competitors

TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Net earnings per share change forecast for next year BEAM|Sarepta (SRPT) - Net earnings per share growth forecast for next year|TWST - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year 10x Genomics, Inc.|NTLA: Expected earnings per share trend next year|Expected earnings per share growth for next year STOK (Stoke Corp)|Consensus forecast of earnings per share growth for next year biolifesolutions.com|Earnings growth forecast for next year WVE (Wave Life Sciences Ltd)|Consensus forecast of earnings per share growth for next year Maze Therapeutics (MAZE)|SION: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Prime Medicine Bio PRME|TSHA: Earnings growth forecast for next year|Projected earnings per share growth rate for next year QURE|Expected earnings per share growth for next year MGTX|Projected earnings per share growth rate for next year RGNX (REGENXBIO)|Earnings growth forecast for next year SLDB|OCGN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Pacific Biosciences of California PACB|BNTC: Projected earnings per share growth rate for next year|DSGN - Net earnings per share growth forecast for next year|RCKT: Net earnings per share growth forecast for next year|FDMT - Projected earnings per share increase next year|Expected net earnings per share growth next year Lexeo Therapeutics Inc. (LXEO)|Net earnings per share growth forecast for next year Korro Bio Inc.|Editas Medicine (EDIT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Silence Therapeutics Inc. (SLN)|PRQR: Net earnings per share change forecast for next year|Earnings growth forecast for next year CDXS (codexis.com)|SGMO: Projected earnings per share growth rate for next year|NAUT: Expected earnings per share growth for next year|Expected net earnings per share growth next year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Generation Bio Corp (GBIO)|Expected earnings per share growth for next year BOLD|exicuretx.com (XCUR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year MBIO (Mustang Bio Corp)|Projected earnings per share increase next year RNAZ (TransCode Therapeutics)|BNGO - Net earnings per share growth forecast for next year|APDN: Net earnings per share growth forecast for next year|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year